Team:Calgary/Project/Achievements
From 2010.igem.org
(Difference between revisions)
Line 135: | Line 135: | ||
<ul> | <ul> | ||
- | <li> | + | <li>Using various methods of characterization, we confirmed that our CpxR reporter circuit was functional. In adition, our maltose binding protein (MalE) and mutant maltose binding protein (MalE31) were shown to be functionalClick <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization"> here</a> for more information.</li> |
- | + | ||
<table> | <table> | ||
<tr> | <tr> | ||
Line 144: | Line 143: | ||
</table> | </table> | ||
- | <li> | + | <li>The CpxR reporter, MalE31, and MalE were shown to be functional through characterization. Click <a href="https://2010.igem.org/Team:Calgary/Parts/Parts"> here</a> for more information.</li> |
- | + | ||
- | < | + | |
<h2 style="color:#0066CC">Gold Medal Requirements</h2> | <h2 style="color:#0066CC">Gold Medal Requirements</h2> | ||
Line 158: | Line 155: | ||
<ul> | <ul> | ||
- | <li> | + | <li>MalE and MalE31 were in the Registry of Standard Parts but were shown to have incorrect information. We submitted DNA and updated what was already present. The information can be found <a href="https://2010.igem.org/Team:Calgary/Parts/Parts_Submitted"> here</a> </li> |
- | <li> | + | <li>More characterization was given to the Registry of Standard Parts on the CpxR promoter.</li> |
</ul> | </ul> | ||
Line 170: | Line 167: | ||
<ul> | <ul> | ||
- | <li>We tested out a part for Lethbridge. We | + | <li>We tested out a part (nms6) for the University of Lethbridge. We assayed it for possible misfolding in the cytoplasm. Results can be found <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization"> here</a>.</li> |
- | + | ||
- | < | + | |
- | <li> | + | <li> We attended an Alberta-wide conference where teams from the University of Calgary, the University of Lethbridge, and the University of Alberta did mock presentations, gave each other future directions, and gave possible troubleshooting methods.</li> |
+ | <li>We filled out surveys for the University of Warsaw and the University of Edinburgh iGEM teams</li> | ||
<li>This year we chose to approach ethics by making a podscasts covering a few different ethical issues pertaining to synthetic biology. We felt tat this would be a novel way to increase awareness about the field of synthetic biology while having a discussion of important issues. We felt that this would be a much more accessible way for the public to gain a better understanding of what the real fears in synthetic biology is as well as to dispel some of the misleading impressions given by media sources.</li> | <li>This year we chose to approach ethics by making a podscasts covering a few different ethical issues pertaining to synthetic biology. We felt tat this would be a novel way to increase awareness about the field of synthetic biology while having a discussion of important issues. We felt that this would be a much more accessible way for the public to gain a better understanding of what the real fears in synthetic biology is as well as to dispel some of the misleading impressions given by media sources.</li> |
Revision as of 02:04, 28 October 2010
Achievements
Bronze Medal Requirements
Register the team | |
Successfully complete and submit a project summary form | |
Create a Wiki which includes all the details of the project | |
Present a presentation and a poster at the iGEM Jamboree | |
Please see our Parts page here. |
Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Parts |
Please see our Parts page here. |
Submit DNA for at least one new BioBrick Part or Device to the Registry of Parts |
Silver Medal Requirements
Demonstrate that one of your parts works as expected |
- Using various methods of characterization, we confirmed that our CpxR reporter circuit was functional. In adition, our maltose binding protein (MalE) and mutant maltose binding protein (MalE31) were shown to be functionalClick here for more information.
- The CpxR reporter, MalE31, and MalE were shown to be functional through characterization. Click here for more information.
- MalE and MalE31 were in the Registry of Standard Parts but were shown to have incorrect information. We submitted DNA and updated what was already present. The information can be found here
- More characterization was given to the Registry of Standard Parts on the CpxR promoter.
- We tested out a part (nms6) for the University of Lethbridge. We assayed it for possible misfolding in the cytoplasm. Results can be found here.
- We attended an Alberta-wide conference where teams from the University of Calgary, the University of Lethbridge, and the University of Alberta did mock presentations, gave each other future directions, and gave possible troubleshooting methods.
- We filled out surveys for the University of Warsaw and the University of Edinburgh iGEM teams
- This year we chose to approach ethics by making a podscasts covering a few different ethical issues pertaining to synthetic biology. We felt tat this would be a novel way to increase awareness about the field of synthetic biology while having a discussion of important issues. We felt that this would be a much more accessible way for the public to gain a better understanding of what the real fears in synthetic biology is as well as to dispel some of the misleading impressions given by media sources.
Characterize the operation of at least one new BioBrick Part or Device and enter this information on the Parts or Device page via the Registry of Parts |
Gold Medal Requirements
Characterize or improve an existing BioBrick Part or Device and enter this information back on the Registry |
Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system |